MULTI REVERSE CONVERTIBLE - DEUTSCHE BANK/BASF/NOVARTIS N Share Price

Certificat

AZXBKB

CH1225282446

Market Closed - Swiss Exchange 09:50:00 21/03/2024 pm IST
101.6 CHF -0.94% Intraday chart for MULTI REVERSE CONVERTIBLE - DEUTSCHE BANK/BASF/NOVARTIS N
1 month-0.63%
3 months-0.54%

Static data

Product typeAktienanleihen
Buy / SellCALL
Underlying NOVARTIS AG
Issuer Basler Kantonalbank
AZXBKB
ISINCH1225282446
Date issued 16/03/2023
Strike 44.22 CHF
Maturity 17/06/2024 (31 Days)
Parity 1 : 1
Emission price 100 CHF
Emission volume N/A
Settlement Beides
Currency CHF

Technical Indicators

Highest since issue 103.1 CHF
Lowest since issue 92.96 CHF
Spread 8.1 CHF
Spread %0.79%

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
102.9 USD
Average target price
107.9 USD
Spread / Average Target
+4.91%
Consensus
  1. Stock Market
  2. Certificates
  3. AZXBKB Certificat
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW